JHS Svendgaard Laboratories Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹1.16 billion
- Book Value:
- Revenue TTM:
- ₹899.23 million
- Operating Margin TTM:
- Gross Profit TTM:
- ₹241.81 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
JHS Svendgaard Laboratories Limited had its IPO on under the ticker symbol JHS.
The company operates in the Consumer Defensive sector and Household & Personal Products industry. JHS Svendgaard Laboratories Limited has a staff strength of 305 employees.
Shares of JHS Svendgaard Laboratories Limited opened at ₹17.1 at the start of the last trading session i.e. 2023-05-28.
The stocks traded within a range of ₹17.1 - ₹18.5, and closed at ₹17.9.
This is a +4.68% increase from the previous day's closing price.
A total volume of 196,199 shares were traded at the close of the day’s session.
In the last one week, shares of JHS Svendgaard Laboratories Limited have increased by 0%.
JHS Svendgaard Laboratories Limited's Key Ratios
JHS Svendgaard Laboratories Limited has a market cap of ₹1.16 billion, indicating a price to book ratio of 0.84 and a price to sales ratio of 1.806.
In the last 12-months JHS Svendgaard Laboratories Limited’s revenue was ₹899.23 million with a gross profit of ₹241.81 million and an EBITDA of ₹-37030248. The EBITDA ratio measures JHS Svendgaard Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, JHS Svendgaard Laboratories Limited’s operating margin was -11.06% while its return on assets stood at -0.79% with a return of equity of 0%.
In Q4, JHS Svendgaard Laboratories Limited’s quarterly earnings growth was a positive 10% while revenue growth was a positive 21.7%.
JHS Svendgaard Laboratories Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹-1.57 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into JHS Svendgaard Laboratories Limited’s profitability.
JHS Svendgaard Laboratories Limited stock is trading at a EV to sales ratio of 1.6238 and a EV to EBITDA ratio of 32.5596. Its price to sales ratio in the trailing 12-months stood at 1.806.
JHS Svendgaard Laboratories Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹2.24 billion
- Total Liabilities
- ₹268.04 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
JHS Svendgaard Laboratories Limited ended 2023 with ₹2.24 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.24 billion while shareholder equity stood at ₹1.82 billion.
JHS Svendgaard Laboratories Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹268.04 million in other current liabilities, 649005000.00 in common stock, ₹1.17 billion in retained earnings and ₹11.07 million in goodwill. Its cash balance stood at ₹78.25 million and cash and short-term investments were ₹191.56 million. The company’s total short-term debt was ₹1,522,000 while long-term debt stood at ₹6.99 million.
JHS Svendgaard Laboratories Limited’s total current assets stands at ₹789.04 million while long-term investments were ₹0 and short-term investments were ₹102.92 million. Its net receivables were ₹191.84 million compared to accounts payable of ₹185.83 million and inventory worth ₹146.10 million.
In 2023, JHS Svendgaard Laboratories Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, JHS Svendgaard Laboratories Limited paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
JHS Svendgaard Laboratories Limited stock is currently trading at ₹17.9 per share. It touched a 52-week high of ₹28.1 and a 52-week low of ₹28.1. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹16.8 and 200-day moving average was ₹20.55 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5998.6% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About JHS Svendgaard Laboratories Limited
Similar Industry Stocks (Household & Personal Products)
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash products, hand sanitizers, laundry detergents, room fresheners, and denture products under the Dr. Gold and Aquawhite brands. It also provides contract manufacturing services for oral care products of other brands; and operates retail stores at airports. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India.